Lawmakers impatient with the lack of progress on a key health care issue — the long-debated need for changes to what’s known ...

The Health Resources and Services Administration has approved eight manufacturer rebate plans under a new 340B pilot program set to launch Jan. 1. The initiative will replace upfront drug discounts ...

Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...

Even as they sparred on broader healthcare policy and funding topics fueling the ongoing government shutdown, senators of the ...

The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan.

WASHINGTON - A Senate health committee met last week to scrutinize the 340B Program, an initiative intended to foster the ...

Lawmakers called for more transparency about how hospitals are using 340B revenue, including audits of participating ...

Lawmakers across the country are working through bills written to shield a growing source of revenue for hospital systems and ...

The US Health Resources and Services Administration (HRSA) has approved nine drugs for a pilot testing a new rebate model ...

Impact: Immediate Savings to Requesting Rebates WATKINSVILLE, GA / ACCESS Newswire / October 28, 2025 / Rural hospitals in the 340B program are about to feel a new financial pressure. On January 1, ...

The US Health Resources and Services Administration (HRSA) revealed the initial nine drugs to be included in the 340B rebate model. The decision comes after pharma companies filed suit in regard to ...

This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of ...